Nanoparticles in drug delivery: From history to therapeutic applications
Current research into the role of engineered nanoparticles in drug delivery systems (DDSs)
for medical purposes has developed numerous fascinating nanocarriers. This paper reviews …
for medical purposes has developed numerous fascinating nanocarriers. This paper reviews …
[HTML][HTML] Advances in chitosan-based nanoparticles for drug delivery
V Mikušová, P Mikuš - International journal of molecular sciences, 2021 - mdpi.com
Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and
medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug …
medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug …
[HTML][HTML] On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
The administration of drugs to the central nervous system (CNS) is primarily controlled by
the blood-brain barrier (BBB), a structure that prevents the passage of foreign compounds …
the blood-brain barrier (BBB), a structure that prevents the passage of foreign compounds …
Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …
[HTML][HTML] Nanotechnology-based drug delivery for central nervous system disorders
Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
Anti-Parkinsonian therapy: strategies for crossing the blood–brain barrier and nano-biological effects of nanomaterials
Abstract Parkinson's disease (PD), a neurodegenerative disease that shows a high
incidence in older individuals, is becoming increasingly prevalent. Unfortunately, there is no …
incidence in older individuals, is becoming increasingly prevalent. Unfortunately, there is no …
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Parkinson's disease (PD) is the second leading neurodegenerative disease globally,
impacting the quality of life of millions of people. It is estimated that the treatment cost of PD …
impacting the quality of life of millions of people. It is estimated that the treatment cost of PD …
Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applications
The blood–brain barrier presents a key limitation to the administration of therapeutic
molecules for the treatment of brain disease. While drugs administered orally or …
molecules for the treatment of brain disease. While drugs administered orally or …
Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers
In recent decades, drug delivery systems (DDSs) based on nanotechnology have been
attracting substantial interest in the pharmaceutical field, especially those developed based …
attracting substantial interest in the pharmaceutical field, especially those developed based …
[HTML][HTML] Access to the CNS: Strategies to overcome the BBB
The blood–brain barrier (BBB) limits the access of substances to the central nervous system
(CNS) which hinders the treatment of pathologies affecting the brain and the spinal cord …
(CNS) which hinders the treatment of pathologies affecting the brain and the spinal cord …